View in EDS HTML Full Text PDF Full Text

Switching from a Non-Protease inhibitor-Based Regimen To the Fixed Dose Combination of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Clinical Practice.

Saved in:
Bibliographic Details
Title: Switching from a Non-Protease inhibitor-Based Regimen To the Fixed Dose Combination of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Clinical Practice.
Authors: Ranzenigo M; Vita-Salute San Raffaele University, Milan, Italy.; Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy., Gianotti N; Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy., Galli L; Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy., Poli A; Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy., Mastrangelo A; Vita-Salute San Raffaele University, Milan, Italy.; Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy., Bruzzesi E; Vita-Salute San Raffaele University, Milan, Italy.; Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy., Chiurlo M; Vita-Salute San Raffaele University, Milan, Italy.; Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy., Nozza S; Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy., Bossolasco S; Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy., Spagnuolo V; Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy., Mancusi D; Medical Affairs Department, Infectious Disease and Vaccines & PAH, Janssen-Cilag SpA, Cologno Monzese, Italy., Termini R; Medical Affairs Department, Infectious Disease and Vaccines & PAH, Janssen-Cilag SpA, Cologno Monzese, Italy., Carini E; Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy., Lazzarin A; Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy., Castagna A; Vita-Salute San Raffaele University, Milan, Italy.; Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Source: Drug design, development and therapy [Drug Des Devel Ther] 2022 Jun 27; Vol. 16, pp. 1975-1982. Date of Electronic Publication: 2022 Jun 27 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: Dove Press Limited Country of Publication: New Zealand NLM ID: 101475745 Publication Model: eCollection Cited Medium: Internet ISSN: 1177-8881 (Electronic) Linking ISSN: 11778881 NLM ISO Abbreviation: Drug Des Devel Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35783200
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Switching from a Non-Protease inhibitor-Based Regimen To the Fixed Dose Combination of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Clinical Practice.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ranzenigo+M%22">Ranzenigo M</searchLink>; Vita-Salute San Raffaele University, Milan, Italy.; Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Gianotti+N%22">Gianotti N</searchLink>; Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Galli+L%22">Galli L</searchLink>; Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Poli+A%22">Poli A</searchLink>; Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Mastrangelo+A%22">Mastrangelo A</searchLink>; Vita-Salute San Raffaele University, Milan, Italy.; Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Bruzzesi+E%22">Bruzzesi E</searchLink>; Vita-Salute San Raffaele University, Milan, Italy.; Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Chiurlo+M%22">Chiurlo M</searchLink>; Vita-Salute San Raffaele University, Milan, Italy.; Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Nozza+S%22">Nozza S</searchLink>; Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Bossolasco+S%22">Bossolasco S</searchLink>; Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Spagnuolo+V%22">Spagnuolo V</searchLink>; Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Mancusi+D%22">Mancusi D</searchLink>; Medical Affairs Department, Infectious Disease and Vaccines & PAH, Janssen-Cilag SpA, Cologno Monzese, Italy.<br /><searchLink fieldCode="AU" term="%22Termini+R%22">Termini R</searchLink>; Medical Affairs Department, Infectious Disease and Vaccines & PAH, Janssen-Cilag SpA, Cologno Monzese, Italy.<br /><searchLink fieldCode="AU" term="%22Carini+E%22">Carini E</searchLink>; Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Lazzarin+A%22">Lazzarin A</searchLink>; Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Castagna+A%22">Castagna A</searchLink>; Vita-Salute San Raffaele University, Milan, Italy.; Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101475745%22">Drug design, development and therapy</searchLink> [Drug Des Devel Ther] 2022 Jun 27; Vol. 16, pp. 1975-1982. <i>Date of Electronic Publication: </i>2022 Jun 27 (<i>Print Publication: </i>2022).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Dove+Press+Limited%22">Dove Press Limited </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>101475745 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1177-8881 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211778881%22">11778881 </searchLink><i>NLM ISO Abbreviation: </i>Drug Des Devel Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35783200
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.2147/DDDT.S358976
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1975
    Titles:
      – TitleFull: Switching from a Non-Protease inhibitor-Based Regimen To the Fixed Dose Combination of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Clinical Practice.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ranzenigo M
      – PersonEntity:
          Name:
            NameFull: Gianotti N
      – PersonEntity:
          Name:
            NameFull: Galli L
      – PersonEntity:
          Name:
            NameFull: Poli A
      – PersonEntity:
          Name:
            NameFull: Mastrangelo A
      – PersonEntity:
          Name:
            NameFull: Bruzzesi E
      – PersonEntity:
          Name:
            NameFull: Chiurlo M
      – PersonEntity:
          Name:
            NameFull: Nozza S
      – PersonEntity:
          Name:
            NameFull: Bossolasco S
      – PersonEntity:
          Name:
            NameFull: Spagnuolo V
      – PersonEntity:
          Name:
            NameFull: Mancusi D
      – PersonEntity:
          Name:
            NameFull: Termini R
      – PersonEntity:
          Name:
            NameFull: Carini E
      – PersonEntity:
          Name:
            NameFull: Lazzarin A
      – PersonEntity:
          Name:
            NameFull: Castagna A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 27
              M: 06
              Text: 2022 Jun 27
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1177-8881
          Numbering:
            – Type: volume
              Value: 16
          Titles:
            – TitleFull: Drug design, development and therapy
              Type: main
ResultId 1